Suppr超能文献

一氧化氮合成抑制对肝硬化大鼠肾脏的影响。

Renal effects of nitric oxide synthesis inhibition in cirrhotic rats.

作者信息

Atucha N M, García-Estañ J, Ramírez A, Pérez M C, Quesada T, Romero J C

机构信息

Departamento de Fisiología, Facultad de Medicina, Murcia, Spain.

出版信息

Am J Physiol. 1994 Dec;267(6 Pt 2):R1454-60. doi: 10.1152/ajpregu.1994.267.6.R1454.

Abstract

In the present study, we have characterized the renal response to inhibition of endogenous nitric oxide (NO) synthesis [intravenous NG-nitro-L-arginine methyl ester (L-NAME) for 3 h] in anesthetized cirrhotic rats, with (ASC) and without (CIR) ascites, at doses that do not change blood pressure (BP). Administration of L-NAME induced opposite effects on water (UV) and sodium (UNaV) excretion in cirrhotic and control animals. Infusion of 1 microgram.kg-1.min-1 of L-NAME in CIR (n = 5) decreased renal plasma flow (RPF) at the end of the 3-h period, whereas UV, UNaV, and glomerular filtration rate (GFR) were unaltered. In contrast, infusion of L-NAME at 10 micrograms.kg-1.min-1 in six more CIR increased UV and UNaV significantly by the 1st h, without changes in BP or GFR, and these parameters remained elevated throughout the experiment. Infusion of 1 microgram.kg-1.min-1 in ASC (n = 6) did not change BP or GFR but significantly enhanced UV and UNaV after the 1st h. These effects were prevented by pretreatment with L-arginine (0.1 mg.kg-1.min-1) in another group of ASC infused with 1 microgram.kg-1.min-1 of L-NAME. These results indicate that, in ASC and CIR cirrhotic rats, inhibition of NO synthesis at nonpressor does improves renal excretion of sodium and water via a decrease in tubular reabsorption. NO is an important mediator of the renal excretory and hemodynamic alterations of experimental liver cirrhosis.

摘要

在本研究中,我们已对麻醉的肝硬化大鼠(有腹水组,ASC;无腹水组,CIR)在不改变血压(BP)的剂量下,对内源性一氧化氮(NO)合成抑制[静脉注射NG-硝基-L-精氨酸甲酯(L-NAME)3小时]的肾脏反应进行了特征描述。给予L-NAME对肝硬化和对照动物的水(UV)和钠(UNaV)排泄产生了相反的影响。在CIR组(n = 5)中,以1微克·千克⁻¹·分钟⁻¹的速度输注L-NAME,在3小时结束时肾血浆流量(RPF)降低,而UV、UNaV和肾小球滤过率(GFR)未改变。相反,在另外6只CIR大鼠中,以10微克·千克⁻¹·分钟⁻¹的速度输注L-NAME,在第1小时时UV和UNaV显著增加,BP和GFR无变化,并且在整个实验过程中这些参数一直升高。在ASC组(n = 6)中,以1微克·千克⁻¹·分钟⁻¹的速度输注L-NAME,BP和GFR无变化,但在第1小时后UV和UNaV显著增加。在另一组输注1微克·千克⁻¹·分钟⁻¹ L-NAME的ASC大鼠中,用L-精氨酸(0.1毫克·千克⁻¹·分钟⁻¹)预处理可防止这些作用。这些结果表明,在ASC和CIR肝硬化大鼠中,在不影响血压的情况下抑制NO合成确实可通过减少肾小管重吸收来改善肾脏对钠和水的排泄。NO是实验性肝硬化肾脏排泄和血流动力学改变的重要介质。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验